SCHEMBL4320180

SCHEMBL4320180

NC(=O)c1ccc2c(c1)OCC2

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.68
PRKCI P41743 1/20 0.50
KDM1A O60341 2/20 0.44
HSP90AA1 P07900 1/20 0.43
NOTUM Q6P988 1/20 0.43
PIK3CA P42336 4/20 0.42
PARP1 P09874 1/20 0.42
PIK3CD O00329 1/20 0.42
PIK3CB P42338 1/20 0.42
PIK3CG P48736 1/20 0.42
NPC1 O15118 1/20 0.42
CASP3 P42574 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
CTNNB1 P35222 1/20 0.41
WNT3A P56704 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30344379 1.00 TSHR (0.68) TSHRPRKCIKDM1AHSP90AA1NOTUM
SCHEMBL28332240 0.91 TSHR (0.62) TSHRPRKCIKDM1ANPC1RAB9A
Hydrogen Sulfide SCHEMBL27600189 0.90 TSHR (0.60) TSHRPRKCIKDM1APIK3CANPC1
SCHEMBL2176489 0.85 PRKCI (0.69) TSHRPRKCINPC1RAB9ACTNNB1
SCHEMBL29503137 0.85 PRKCI (0.69) TSHRPRKCINPC1RAB9ACTNNB1
SCHEMBL4685014 0.85 ALDH1A1 (0.55) TSHRPRKCINPC1RAB9AKDM4E
SCHEMBL19932401 0.84 TSHR (0.47) TSHRPRKCINPC1RAB9ACTNNB1
SCHEMBL1182047 0.84 KDM4E (0.60) TSHRPRKCINPC1RAB9ACTNNB1
Hydrochloric Acid SCHEMBL28130087 0.84 PRKCI (0.67) TSHRPRKCINPC1RAB9ACTNNB1
SCHEMBL624490 0.81 TSHR (1.00) TSHRNPC1CASP3RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107001362-A Heteroaryl compound as BTK inhibitor and application thereof 默克专利有限公司 2017-08-01 CN disclosed
WO-2016156872-A1 QUINOLINE DERIVATIVES AS INHIBITORS OF HEAT SHOCK FACTOR 1 PATHWAY ACTIVITY CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2016-10-06 WO disclosed
US-20090311217-A1 3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES WYETH (US) 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090311217-A1 3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES MTOR, RICTOR, PDPK1 TSHR 3312/4885PRKCI 472/4885KDM1A 1038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.